跳至主要内容
临床试验/NCT03947346
NCT03947346已完成不适用

Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2019年5月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1
主要终点
indicators of renal injury

研究概览

简要总结

The main purpose of this study is to learn more about biomarkers of kidney function in the blood and urine of neuroblastoma survivors. A biomarker is a biological molecule found in blood, urine, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of neuroblastoma between 0-18 years of age
  • < 21 years of age at time of study enrollment
  • Two or more years from completion of systemic chemotherapy and/or radiation therapy

排除标准

  • Patients treated with observation only
  • Patients with multiple primary cancers

结局指标

主要结局

indicators of renal injury

时间窗: 2 years

urine collected from the first morning void will be used to assess urine creatinine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验